Heart Test Laboratories, Inc., a company listed in the United States, has filed definitive additional materials with the Securities and Exchange Commission (SEC) as part of its proxy solicitation process. This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by the registrant, Heart Test Laboratories, Inc., indicating that the company is directly involved in the solicitation of proxies from its shareholders. The filing confirms that no additional filing fee is required. This step is typically part of the company's preparation for upcoming shareholder meetings where important decisions are made, and it ensures that shareholders have the necessary information to vote on corporate matters.

Heart Test Laboratories, Inc., a company listed in the United States, has filed definitive additional materials with the Securities and Exchange Commission (SEC) as part of its proxy solicitation process. This filing, known as Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by the registrant, Heart Test Laboratories, Inc., indicating that the company is directly involved in the solicitation of proxies from its shareholders. The filing confirms that no additional filing fee is required. This step is typically part of the company's preparation for upcoming shareholder meetings where important decisions are made, and it ensures that shareholders have the necessary information to vote on corporate matters.